Clinical trial
Protection Against Emboli During caRotid Artery Stenting Using a Neuroguard IEP® Direct 3-in-1 Delivery System Comprised oF a pOst-dilation Balloon, integRated eMbolic Filter, and A Novel Carotid stEnt - the PERFORMANCE III Study
NCT05845710 is registered in ClinicalTrials.gov with Contego Medical, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Protection Against Emboli During caRotid Artery Stenting Using a Neuroguard IEP® Direct 3-in-1 Delivery System Comprised oF a pOst-dilation Balloon, integRated eMbolic Filter, and A Novel Carotid stEnt - the PERFORMANCE III Study
- Lead sponsor
- Contego Medical, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 5, 2023
- Completion date
- August 12, 2025
- Enrollment
- 178 (actual)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.